1-4 of 4
Philip D Greenberg, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EBV-Specific Donor Cells Transduced to Express a High-Affinity WT1 TCR Can Prevent Recurrence in Post-HCT Patients with High-Risk AML

Aude Chapuis, MD, Daniel N. Egan, MD, Merav Bar, MD, Thomas M Schmitt, PhD, Megan McAfee, PhD, Maurizio Perdicchio, PhD, Gunnar B. Ragnarsson, MD MSc, Cecilia C.S. Yeung, Hieu Nguyen, Lara Kropp, Luca Castelli, PhD, Felecia Wagener, Daniel Hunter, Kristen Cohen, PhD, Aaron Seese, Margaret (Julie) McElrath, MD PhD, Kieu-Thu Bui, RN, Deborah E Banker, PhD, Natalie Duerkopp, Philip D Greenberg, MD
Journal: Blood
Blood (2016) 128 (22): 1001.
https://doi.org/10.1182/blood.V128.22.1001.1001
Published: 2016
Journal Articles

Transferred Donor-Derived Virus Specific CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor Can Persist and Provide Anti-Leukemic Activity in AML Patients Post-Transplant

Merav Bar, MD, Aude G. Chapuis, MD, Thomas M Schmitt, PhD, Hieu Nguyen, Natalie A Duerkopp, Mark F Tom, Felecia D Wagener, Colette N Chaney, RN, Kieu-Thu Bui, RN, Shelly Heimfeld, PhD, Philip D. Greenberg, MD
Journal: Blood
Blood (2014) 124 (21): 3939.
https://doi.org/10.1182/blood.V124.21.3939.3939
Published: 2014
Journal Articles

TCR Gene Editing Results in Effective Immunotherapy of Leukemia without the Development of GvHD

Elena Provasi, PhD, Pietro Genovese, Angelo Lombardo, PhD, Zulma Magnani, Pei-Qi Liu, Andreas Reik, Victoria Chu, David E Paschon, Lei Zhang, Jurgen Kuball, MD, PhD, Barbara Camisa, Attilio Bondanza, MD, PhD, Giulia Casorati, PhD, Maurilio Ponzoni, MD, Fabio Ciceri, MD, Claudio Bordignon, MD, Philip D. Greenberg, MD, Michael C. Holmes, PhD, Philip D. Gregory, PhD, Luigi Naldini, MD, PhD, Chiara Bonini, MD
Journal: Blood
Blood (2011) 118 (21): 667.
https://doi.org/10.1182/blood.V118.21.667.667
Published: 2011
Journal Articles

Adoptive Cellular Therapy for Follicular Lymphoma Using Genetically-Modified Autologous CD20-Specific T Cells.

Brian G. Till, MD, Michael C. Jensen, MD, Jinjuan Wang, MD, Eric Y. Chen, MD, PhD, Scott James, PhD, Andrew Raubitschek, MD, Stephen J. Forman, MD, Ajay K. Gopal, MD, John M. Pagel, MD, PhD, Catherine G. Lindgren, Philip D. Greenberg, MD, Stanley R. Riddell, MD, Oliver W. Press, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 499.
https://doi.org/10.1182/blood.V110.11.499.499
Published: 2007